EXPLORE MORE CATEGORIES
- Home
- ยป
- Our Products
- »
- Antidiabetic Drugs
Antidiabetic Drugs
Providing you the best range of gliclazide (40mg),metformin (500 mg), dapagliflozin 5mg tablet, sitagliptin phosphate and metformin hydrochloride tablets, imeglimin hydrochloride 500 mg, repaglinide (0.5mg), voglibose (0.3mg) and gliclazide 60mg mr tablet with effective & timely delivery.
gliclazide (40mg),Metformin (500 mg)
Product Price: Rs 30 / StripeGet Best Price
Minimum Order Quantity: 1 Stripe
Product Brochure
Product Details:
| Metformin Strength | 500 mg |
| Strength | 40mg/500mg |
| Gliclazide Strength | 40 mg |
| Release Type | Immediate |
| Pack Type | Strip |
| Brand | Gliclaglaze M40 |
| Packing Type | Strip |
| Tablets Per Strip | 15 tablets |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Prescription / Non Prescription | Prescription |
| Also gives | PCD Pharma Franchise |
| Country of Origin | Made in India |
Combining Gliclazide and Metformin, with dosages of 40 mg for Gliclazide and 500 mg for Metformin, is a common approach in the treatment of type 2 diabetes mellitus. This combination leverages the complementary mechanisms of action of the two medications to better control blood glucose levels.
Gliclazide is a sulfonylurea, which works by stimulating the release of insulin from the beta cells in the pancreas. This results in a decrease in blood sugar levels. The specific dose of 40 mg is designed to effectively manage blood sugar levels, and it must be adjusted based on the individual patient's response and needs.
Metformin, on the other hand, is a biguanide, which works by decreasing glucose production in the liver, improving insulin sensitivity, and facilitating glucose uptake by the muscles. The dose of 500 mg is often used as a starting point for treatment, and it can be adjusted based on the patient's tolerance and the effectiveness of blood sugar control.
Using Gliclazide and Metformin together provides a more comprehensive approach to managing type 2 diabetes by targeting different aspects of the disease. While Gliclazide directly stimulates insulin secretion, Metformin works to improve the body's use of insulin and reduce the amount of glucose the liver releases into the bloodstream.
Patients on this combination therapy should monitor their blood sugar levels closely and adhere to their prescribed dietary and exercise regimen to achieve the best outcomes. Side effects can include hypoglycemia (especially with Gliclazide), gastrointestinal disturbances, and lactic acidosis (a rare but serious side effect of Metformin). Regular follow-up with a healthcare provider is crucial to adjust the medication doses as needed and to monitor for any adverse effects.
It's also important for patients to be aware of the signs of hypoglycemia (such as dizziness, sweating, and confusion) and how to manage them, considering the risk associated with sulfonylureas like Gliclazide. Collaboration between the patient and healthcare professionals is key to optimizing treatment and managing type 2 diabetes effectively.
Yes! I am InterestedRequest A Callback
Dapagliflozin 5mg Tablet
Product Price: Rs 105 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 5 mg |
| Composition | dapagliflozin 5 mg |
| Pack Size | 15 tablets |
| Usage | Type 2 Diabetes |
| Prescription Type | Rx Only |
| Form | Tablets |
| Packaging Size | 4*15 |
| Packaging Type | ALU-ALU |
| BRAND | GLIDAPAFLOZIN 5 |
GLIDAPAFLOZIN 5 contains Dapagliflozin 5 mg, a highly effective antidiabetic medicine formulated by Steris Healthcare to help manage blood sugar levels in adults with Type 2 Diabetes Mellitus. Dapagliflozin belongs to a class of drugs known as SGLT2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors), which work by helping the kidneys remove excess glucose from the bloodstream through urine.
This advanced oral diabetes medication is designed to provide better glycemic control, improve insulin sensitivity, and help reduce the risk of diabetes-related complications such as neuropathy, nephropathy, and cardiovascular issues. Regular use of GLIDAPAFLOZIN 5 helps patients maintain stable blood sugar levels, manage body weight effectively, and support overall metabolic health.
Manufactured under strict WHO-GMP-certified conditions, GLIDAPAFLOZIN 5 ensures the highest standards of quality, purity, and safety. It can be prescribed alone or in combination with other antidiabetic medications such as Metformin, Glimepiride, or Sitagliptin, depending on the doctor’s advice.
Key Benefits:
-
Helps control and lower high blood sugar levels in Type 2 Diabetes.
-
Promotes weight loss and reduces visceral fat accumulation.
-
Lowers blood pressure and supports cardiovascular health.
-
Enhances kidney function by promoting glucose excretion.
-
Convenient once-daily oral tablet for easy dosage management.
Note: GLIDAPAFLOZIN 5 should be taken only under medical supervision. It is not recommended for patients with Type 1 Diabetes or severe kidney disease.
For effective diabetes management, choose GLIDAPAFLOZIN 5 – Dapagliflozin 5 mg Tablets from Steris Healthcare, trusted for quality, safety, and reliable healthcare solutions.
Yes! I am InterestedRequest A Callback
sitagliptin phosphate and metformin hydrochloride tablets
Product Price: Rs 520.31 / StripGet Best Price
Product Brochure
Product Details:
| Metformin Strength | 1000 mg |
| Strength | 100mg/1000mg |
| Sitagliptin Strength | 100 mg |
| Release Type | Sustained |
| Packaging Size | 1*10 Tablets |
| Brand | GLISITAPTIN M KIT |
| Packing Type | Strip |
| Tablets Per Strip | 4 kit |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usage/Application | Reduction of HbA1c levels |
| Packaging Type | Box |
GLISITAPTIN M KIT is a powerful anti-diabetic combination therapy containing sitagliptin phosphate 100 mg and metformin hydrochloride 1000 mg. It is used in the effective management of Type 2 Diabetes Mellitus, helping patients control high blood sugar levels and reduce the risk of diabetic complications. This dual-action therapy improves insulin sensitivity and enhances natural insulin production.
If you're looking for a reliable formulation of sitagliptin phosphate and metformin hydrochloride tablets, GLISITAPTIN M KIT is designed to deliver clinically proven results with better glycemic control and fewer side effects.
What is Sitagliptin Phosphate and Metformin Hydrochloride?
Sitagliptin Phosphate is a DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases the levels of incretin hormones, enhancing insulin release and reducing glucose production in the liver.
Metformin Hydrochloride is a biguanide that works by improving insulin sensitivity and reducing hepatic glucose output. It also decreases intestinal absorption of glucose.
Together, they form a synergistic combination that offers better control of blood sugar in patients with Type 2 Diabetes Mellitus.
Uses of Sitagliptin Phosphate and Metformin Hydrochloride Tablets
GLISITAPTIN M KIT is prescribed for:
-
Type 2 Diabetes Mellitus management in adults
-
Inadequate glycemic control on metformin alone
-
Reduction of HbA1c levels
-
Improving insulin sensitivity and glucose utilization
-
Delaying progression of diabetic complications such as neuropathy, retinopathy, and nephropathy
metformin hydrochloride 1000 mg uses also include management of insulin resistance and metabolic syndrome in overweight individuals.
Side Effects of Sitagliptin Phosphate and Metformin Hydrochloride Tablets
While generally well-tolerated, some patients may experience:
-
Nausea or vomiting
-
Diarrhea or abdominal discomfort
-
Loss of appetite
-
Headache
-
Weakness or fatigue
-
Flatulence
Rare but serious side effects include:
-
Lactic acidosis (a rare, life-threatening condition with metformin)
-
Pancreatitis (in rare cases due to sitagliptin)
-
Hypoglycemia (especially when used with other anti-diabetics)
Before starting GLISITAPTIN M KIT, consult your physician if you:
-
Have kidney or liver impairment
-
Are pregnant or breastfeeding
-
Consume alcohol frequently
-
Have a history of heart failure or lactic acidosis
-
Undergo any surgery or medical imaging requiring contrast dye
Patients with vitamin B12 deficiency should be monitored during prolonged metformin therapy.
Drug Interactions
The combination of sitagliptin phosphate and metformin hydrochloride tablets may interact with the following:
-
Diuretics (e.g., furosemide) – may increase risk of lactic acidosis
-
Insulin or sulfonylureas – may increase risk of hypoglycemia
-
Cimetidine – may affect metformin elimination
-
Iodinated contrast media – may increase the risk of acute renal failure
-
Alcohol – enhances metformin’s effect on lactate metabolism, increasing lactic acidosis risk
Yes! I am InterestedRequest A Callback
Imeglimin Hydrochloride 500 mg
Product Price: Rs 149 / BoxGet Best Price
Product Brochure
Product Details:
| Country of Origin | Made in India |
| Brand | IMEGLIMON 500 |
| Manufactured By | Steris Healthcare Pvt Ltd |
| Composition | Imeglimin Hydrochloride 500 mg |
| Package SIZE | 5*3*10 |
Imeglimin Hydrochloride, marketed under the brand name IMEGLIMON 500, is a novel oral antihyperglycemic agent designed for the management of type 2 diabetes. It represents a unique class of medication that offers a dual mechanism of action to improve blood sugar control.
How Does It Work?
Imeglimin Hydrochloride works by:
- Enhancing insulin sensitivity in the muscles
- Reducing glucose production in the liver
- Improving pancreatic beta-cell function
Uses of Imeglimin Hydrochloride 500 mg
IMEGLIMON 500 is primarily used for:
- Managing type 2 diabetes mellitus
- Helping control blood glucose levels in conjunction with diet and exercise
- Potentially used alongside other antidiabetic medications for better glycemic control
What is Imeglimin Hydrochloride?
Imeglimin Hydrochloride is an oral medication that belongs to a new class of antidiabetic agents. It addresses multiple aspects of type 2 diabetes, offering a comprehensive approach to managing the condition.
Side Effects
Common side effects of IMEGLIMON 500 may include:
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Fatigue
When using IMEGLIMON 500:
- Monitor blood glucose levels regularly
- Discuss any other medications you are taking with your healthcare provider
- Report any severe side effects to your doctor immediately
- Use with caution if you have a history of liver or kidney issues
Yes! I am InterestedRequest A Callback
Repaglinide (0.5mg), Voglibose (0.3mg)
Product Price: Rs 135.94 / BoxGet Best Price
Product Brochure
Product Details:
| Strength | 0.5 |
| Composition | Repaglinide+Voglibose |
| Form | Tablets |
| Usage | Type 2 Diabetes |
| Pack Size | 10 tablets |
| Release Type | Immediate Release |
| Packaging Size | 10*10 |
| Packaging Type | ALU-AU |
| Country of Origin | Made in India |
| brand | RAPIGLINIDE VOG 0.5 |
| Manufactured By | Steris Healthcare Pvt Ltd |
| storage | keep in a cool and dry place |
RAPIGLINIDE VOG 0.5 is a combination medication designed to manage blood glucose levels in individuals with type 2 diabetes. It combines Repaglinide, a meglitinide analog, and Voglibose, an alpha-glucosidase inhibitor. This formulation aims to improve glycemic control by targeting different mechanisms involved in glucose regulation.
How Does It Work?
- Repaglinide (0.5mg): Stimulates the pancreas to release insulin, reducing blood sugar levels after meals.
- Voglibose (0.3mg): Slows down carbohydrate absorption in the intestines, preventing post-meal spikes in blood glucose.
- Type 2 Diabetes Management: Helps maintain blood sugar levels within the target range.
- Postprandial Hyperglycemia: Reduces blood sugar spikes after meals, essential for overall glucose control.
RAPIGLINIDE VOG 0.5 is a dual-action oral antidiabetic medication. By combining Repaglinide and Voglibose, it provides a comprehensive approach to managing postprandial blood glucose levels, making it effective for type 2 diabetes patients.
Side Effects
- Common: Hypoglycemia, gastrointestinal disturbances (diarrhea, nausea), headache.
- Serious: Severe hypoglycemia, allergic reactions, liver function abnormalities.
- Monitoring: Regular blood sugar monitoring is essential to avoid hypoglycemia.
- Diet and Exercise: Follow a balanced diet and exercise regimen as advised by your healthcare provider.
- Interactions: Inform your doctor about all medications and supplements you are taking to avoid potential interactions.
- Pregnancy and Breastfeeding: Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding.
Yes! I am InterestedRequest A Callback
Gliclazide 60mg Mr Tablet
Product Price: Rs 30 / StripeGet Best Price
Product Brochure
Product Details:
| Strength | 60 mg |
| Release Type | MR |
| Form | Tablets |
| Pack Size | 15 tablets |
| Composition | Gliclazide SR 60 mg |
| Brand | GLICLAGALZE MR 60 |
| Usage | Type 2 Diabetes |
| Prescription/Non prescription | Prescription |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Also gives | PCD Pharma Franchise |
Gliclazide SR (Sustained Release) 60 mg is a medication primarily used in the management of type 2 diabetes mellitus. It belongs to a class of drugs known as sulfonylureas, which work by increasing the release of insulin from the pancreas. This results in lower blood sugar levels. The "SR" in its name stands for "Sustained Release," which means the medication is formulated to release the active ingredient slowly over time, providing a more consistent effect and often with the convenience of fewer doses per day, usually once daily.
Gliclazide SR is effective in controlling blood sugar levels, thereby reducing the risk of diabetes-related complications such as heart disease, kidney damage, and vision problems. It is important to use this medication under the guidance of a healthcare professional, as it requires careful monitoring of blood sugar levels and may need to be adjusted based on individual response and any other medications being taken. Additionally, managing type 2 diabetes effectively also involves lifestyle changes, including diet, exercise, and weight management.
Common side effects of gliclazide SR include hypoglycemia (low blood sugar levels), gastrointestinal disturbances (such as nausea and indigestion), and skin reactions. Severe hypoglycemia is less common but can be serious and requires immediate medical attention. Patients are often advised to carry some form of sugar with them to counteract symptoms of low blood sugar quickly.
It's important for individuals taking gliclazide SR to maintain regular follow-up appointments with their healthcare provider to monitor their condition and make any necessary adjustments to their treatment plan.
Yes! I am InterestedRequest A Callback
Glimepiride (1mg) & Metformin SR (1000mg)
Product Price: Rs 30 / StripeGet Best Price
Product Brochure
Product Details:
| Metformin Strength | 1000 mg |
| Packaging Size | 2*15 Tablets |
| Glimepiride Strength | 1 mg |
| Release Type | Prolonged |
| Pack Type | Strip |
| Brand | glimiteris m1 forte |
| Packing Type | Strip |
| Tablets Per Strip | 15 tablets |
| Manufacturer | STERIS Healthcare Pvt. Ltd. |
| Prescription / Non Prescription | Prescription |
| Also gives | PCD Pharma Franchise |
| Country of Origin | Made in India |
| Packaging Type | Box |
GLIMETAWIN SR 1/1000: The Dual-Action Solution for Diabetes Management
In the realm of diabetes management, GLIMETAWIN SR 1/1000 emerges as a groundbreaking solution, combining the efficacy of Glimepiride and Metformin in a single, potent formulation. This comprehensive medication is designed to cater to the needs of individuals grappling with type 2 diabetes, offering a synergistic approach to control blood sugar levels effectively.
How GLIMETAWIN SR 1/1000 Works
GLIMETAWIN SR 1/1000 is a combination of two active ingredients, Glimepiride and Metformin SR, each playing a crucial role in managing blood glucose levels. Glimepiride belongs to the class of drugs known as sulfonylureas, which stimulate the pancreas to release more insulin, thus reducing blood sugar levels. Metformin, on the other hand, is a biguanide that works by decreasing glucose production in the liver and improving the body's sensitivity to insulin.
The sustained-release (SR) formulation of Metformin in GLIMETAWIN SR 1/1000 ensures a gradual release of the medication in the body, leading to steady blood sugar control throughout the day without sudden spikes or drops. This feature makes it an ideal choice for individuals seeking long-lasting glycemic control.
Benefits of GLIMETAWIN SR 1/1000
- Enhanced Blood Sugar Control: By combining Glimepiride and Metformin, GLIMETAWIN SR 1/1000 offers a dual mechanism of action, helping to lower blood glucose levels more effectively than either medication alone.
- Convenient Dosage Regimen: With both active ingredients combined into one tablet, GLIMETAWIN SR 1/1000 simplifies the daily medication routine, making it easier to adhere to the treatment plan.
- Reduced Risk of Side Effects: The SR formulation of Metformin minimizes the risk of gastrointestinal side effects, which are commonly associated with standard Metformin therapy.
Ideal Candidates for GLIMETAWIN SR 1/1000
GLIMETAWIN SR 1/1000 is particularly suitable for individuals with type 2 diabetes who have not achieved optimal blood sugar control with diet and exercise alone or with single-agent therapy. It is ideal for patients looking for an efficient and manageable diabetes treatment regimen.
Conclusion
GLIMETAWIN SR 1/1000 stands out as an innovative and reliable option for managing type 2 diabetes. Its unique combination of Glimepiride and Metformin SR offers a comprehensive solution that ensures effective and sustained blood sugar control. By integrating this medication into their diabetes management plan, individuals can take a significant step towards achieving better health outcomes and improving their quality of life.
Yes! I am InterestedRequest A Callback
Sitagliptin Phosphate Tablets 100 Mg
Product Price: Rs 464.06 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 100 mg |
| Dose/Strength | 100 mg |
| Composition | Sitagliptin |
| Pack Size | 15 tablets |
| Packaging Size | 4*15 |
| Brand | Glisitaptin |
| Release Type | Immediate Release |
| Usage | Type 2 Diabetes |
| Packaging Type | Stripe |
| Manufacturer | Steris Healthcare Pvt Ltd |
| Usage/Application | Hospital |
| Shelf Life | 24months |
GLISITAPTIN 100 is an advanced oral anti-diabetic medicine containing Sitagliptin Phosphate 100 mg, a powerful DPP-4 inhibitor that helps improve glycemic control in adults with type 2 diabetes mellitus. Trusted by doctors, sitagliptin phosphate tablets are used either alone or in combination with other medications like metformin or sulfonylureas to lower blood sugar levels without causing hypoglycemia.
What is Sitagliptin Phosphate?
Sitagliptin phosphate is an oral antihyperglycemic agent that belongs to the class of drugs called DPP-4 (dipeptidyl peptidase-4) inhibitors. It works by increasing the levels of incretin hormones, which regulate insulin release and suppress glucagon secretion in a glucose-dependent manner. GLISITAPTIN 100 contains sitagliptin phosphate tablets IP 100 mg, formulated under strict pharmaceutical standards to ensure purity, potency, and long-lasting glycemic control.
Uses of Sitagliptin Phosphate TabletsHere are the primary sitagliptin phosphate tablets uses:
-
Control of Type 2 Diabetes Mellitus
Helps lower elevated blood sugar levels in adults with type 2 diabetes, especially in combination with diet and exercise. -
Monotherapy or Combination Therapy
Used as monotherapy or in combination with metformin, sulfonylureas, thiazolidinediones, or insulin. -
Improves Glycemic Control
Maintains stable blood sugar without significant risk of hypoglycemia or weight gain. -
Cardiometabolic Protection (as per recent studies)
Emerging data suggests potential cardiovascular safety in patients with type 2 diabetes.
Most people tolerate GLISITAPTIN 100 well, but some may experience:
-
Headache
-
Nasopharyngitis (cold-like symptoms)
-
Nausea or stomach discomfort
-
Upper respiratory tract infection
-
Diarrhea
-
Joint pain (rare)
-
Pancreatitis (very rare, but serious)
Stop the medication and consult your physician immediately if symptoms of allergic reaction, severe stomach pain, or difficulty breathing occur.
Precautions Before Using Sitagliptin Phosphate TabletsBefore starting GLISITAPTIN 100, inform your doctor if you:
-
Have a history of pancreatitis
-
Suffer from kidney impairment or are on dialysis
-
Are pregnant or planning pregnancy
-
Are breastfeeding
-
Have a history of allergic reactions to sitagliptin or other DPP-4 inhibitors
Sitagliptin generally has low drug interaction potential, but inform your healthcare provider if you're using:
-
Insulin or sulfonylureas – May increase risk of hypoglycemia
-
Diuretics (e.g., furosemide) – May cause dehydration or impact kidney function
-
ACE inhibitors – Combined use may increase risk of angioedema
-
Corticosteroids – Can elevate blood sugar levels
-
Digoxin – Sitagliptin may slightly increase digoxin levels
Purchasing Sitagliptin Phosphate 100 mg tablets from Steris Healthcare is simple, reliable, and customer-focused. As a trusted name in the Indian pharmaceutical industry, Steris Healthcare ensures that high-quality, GMP-certified diabetic medications like Sitagliptin are readily accessible to healthcare providers, distributors, and patients across India.
Yes! I am InterestedRequest A Callback
Linagliptin 2.5 mg
Product Price: Rs 192.19 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 2.5 mg |
| Composition | Linagliptin 2.5 mg |
| Pack Size | 4X15 |
| Brand | Linaliglip |
| Usage | Type 2 Diabetes |
| Prescription Type | Rx Only |
| Form | Tablets |
| Packaging Size | 4*15 |
| Packaging Type | ALU-ALU |
| Country of Origin | Made in India |
LINALIGLIP 2.5 is a prescription medication that contains the active ingredient Linagliptin 2.5 mg, specifically formulated for the management of type 2 diabetes mellitus. This condition is characterized by high blood sugar levels due to the body's inability to produce enough insulin or effectively use the insulin it produces. LINALIGLIP 2.5 is designed to aid blood sugar control in adults when lifestyle changes such as diet and exercise are insufficient. It is part of a modern therapeutic approach that helps patients achieve better glycemic control and reduce the risk of diabetic complications through improved insulin regulation.
What is LINALIGLIP 2.5?
LINALIGLIP 2.5 is an oral antidiabetic medicine that belongs to the class of drugs known as Dipeptidyl Peptidase-4 (DPP-4) inhibitors. Its active ingredient, Linagliptin 2.5 mg, works by modulating hormone levels that influence blood glucose. This medication enhances the body's ability to manage blood sugar levels effectively, especially after meals, by helping regulate the release of insulin and reducing glucose production by the liver.
Uses of LINALIGLIP 2.5
-
Management of blood glucose levels in adults with type 2 diabetes mellitus.
-
Used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin.
-
Helps reduce the risk of diabetes-related complications by improving glycemic control.
-
Supports patients whose blood sugar levels remain uncontrolled despite diet, exercise, or other oral antidiabetic medications.
How LINALIGLIP 2.5 Works
Linagliptin 2.5 mg is a medication used to treat type 2 diabetes. It belongs to a class of drugs called DPP-4 inhibitors, which help lower blood sugar levels by increasing the amount of insulin released after meals and reducing the amount of glucose released by the liver. It achieves this by inhibiting the DPP-4 enzyme, thus increasing the levels of incretin hormones that regulate insulin secretion and glucagon suppression.
Side Effects of LINALIGLIP 2.5
-
Hypoglycemia (low blood sugar), especially when taken with other diabetes medicines.
-
Nasopharyngitis (symptoms resembling to common cold such as a runny or stuffy nose).
-
Headache and dizziness.
-
Gastrointestinal issues like nausea, vomiting, diarrhea, or constipation.
-
Rare but serious effects may include pancreatitis (inflammation of the pancreas) and allergic reactions such as rash or hives.
Patients should report severe or persistent side effects to their healthcare provider promptly.
Precautions Before Using LINALIGLIP 2.5
-
Inform your doctor about any history of pancreatitis, kidney or liver disease, or heart conditions.
-
Regular blood sugar monitoring is essential to adjust dosages and avoid complications.
-
Continue with prescribed diet and exercise regimens to maximize medication efficacy.
-
Avoid excessive alcohol intake as it may increase the risk of pancreatitis and other side effects.
-
Do not discontinue the medication without consulting your healthcare provider, even if blood sugar levels improve.
Drug Interactions: What Drugs Interact With LINALIGLIP 2.5?
-
May interact with other antidiabetic medications such as insulin, sulfonylureas (e.g., glimepiride, glipizide), which can increase the risk of hypoglycemia.
-
Yes! I am InterestedRequest A Callback
Dapagliflozin 10 mg,Teneligliptin 20 mg & Metformin Hydrochloride 1000 mg Extended Release Tablets
Product Price: Rs 156.66 / StripGet Best Price
Product Brochure
Product Details:
| Metformin Strength | 1000 mg |
| Dapagliflozin Strength | 10 mg |
| Release Type | Extended |
| Brand | Steris Pharma |
| Packing Type | Strip |
| Tablets Per Strip | 15 tablets |
| Prescription | Prescription |
| Form | Tablet |
| Shelf Life | 24 months |
| Country Of Origin | India |
Managing Type 2 Diabetes requires an effective treatment approach that helps control blood sugar levels while supporting overall metabolic health. Modern diabetes care often involves combination therapies that target different pathways responsible for high blood glucose. GLIDAPA TENMET 1000 tablets are designed as a powerful triple-combination therapy to help patients achieve better glycemic control.
This innovative formulation combines Dapagliflozin, Teneligliptin, and Metformin Hydrochloride (Extended Release). Together, these medications work through complementary mechanisms to control blood sugar levels, improve insulin efficiency, and support long-term diabetes management.
GLIDAPA TENMET 1000 tablets are widely used in the treatment of adults with Type 2 Diabetes who require combination therapy to maintain optimal glucose control.
What is GLIDAPA TENMET 1000?GLIDAPA TENMET 1000 is a triple-action anti-diabetic tablet formulated to help manage high blood sugar levels in patients with Type 2 Diabetes. It contains three clinically proven ingredients that work together to improve glycemic control and reduce the risk of complications related to diabetes.
This medication is particularly beneficial for patients who do not achieve adequate blood sugar control with single or dual therapy. By combining three powerful mechanisms in one tablet, GLIDAPA TENMET 1000 simplifies treatment while enhancing effectiveness.
Composition of GLIDAPA TENMET 1000 TabletsEach GLIDAPA TENMET 1000 tablet contains the following active ingredients:
-
Dapagliflozin 10 mg
-
Teneligliptin 20 mg
-
Metformin Hydrochloride 1000 mg (Extended Release)
These ingredients work through different pathways to regulate glucose metabolism and improve insulin response.
Role of Active IngredientsDapagliflozin
Dapagliflozin belongs to a class of medicines known as SGLT2 inhibitors. It works by helping the kidneys remove excess glucose from the bloodstream through urine.
Key benefits include:
-
Lowering blood sugar levels
-
Supporting weight management
-
Helping improve cardiovascular outcomes in certain patients
By eliminating excess glucose through urine, Dapagliflozin helps reduce blood sugar without directly increasing insulin production.
Teneligliptin
Teneligliptin is a DPP-4 inhibitor that helps improve the body's natural ability to control blood glucose levels. It works by increasing the levels of incretin hormones that stimulate insulin release after meals.
Benefits of Teneligliptin include:
-
Enhancing insulin secretion when needed
-
Reducing glucagon production
-
Improving post-meal blood sugar control
This mechanism helps maintain stable glucose levels throughout the day.
Metformin Hydrochloride (Extended Release)
Metformin Hydrochloride is one of the most widely prescribed medications for Type 2 Diabetes. In its extended-release form, it provides long-lasting glucose control with improved gastrointestinal tolerance.
Metformin works by:
-
Reducing glucose production in the liver
-
Improving insulin sensitivity
-
Enhancing glucose uptake by body tissues
The extended-release formulation ensures gradual absorption, allowing sustained blood sugar control.
Yes! I am InterestedRequest A Callback
Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets
Product Price: Rs 227.50 / StripGet Best Price
Product Brochure
Product Details:
| Metformin Strength | 500 mg |
| Dapagliflozin Strength | 10 mg |
| Release Type | Sustained |
| Brand | Steris Pharma |
| Packing Type | Alu Alu |
| Tablets Per Strip | 15 tablets |
| Prescription | Prescription |
| Form | Tablet |
| Shelf Life | 24 months |
| Country Of Origin | India |
Managing type 2 diabetes effectively often requires a combination approach—and that’s where DAPAVILDA MET 10/100/500 comes in. This advanced triple-combination tablet brings together Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg to help control blood sugar levels through multiple mechanisms.
What is DAPAVILDA MET 10/100/500?DAPAVILDA MET 10/100/500 is an oral anti-diabetic medication designed for adults with type 2 diabetes mellitus. It combines three powerful agents that work synergistically to improve glycemic control.
Composition:
- Dapagliflozin 10 mg
- Vildagliptin SR 100 mg
- Metformin SR 500 mg
This triple therapy targets different pathways involved in blood sugar regulation, making it highly effective for patients who are not adequately controlled on single or dual therapy.
How DAPAVILDA MET 10/100/500 WorksEach component plays a unique role:
1. Dapagliflozin (SGLT2 Inhibitor)
- Removes excess glucose through urine
- Reduces blood sugar independently of insulin
2. Vildagliptin SR (DPP-4 Inhibitor)
- Increases incretin hormones
- Enhances insulin release after meals
- Reduces glucagon levels
3. Metformin SR (Biguanide)
- Decreases glucose production in the liver
- Improves insulin sensitivity
- Delays glucose absorption from the intestine
Together, these actions provide comprehensive blood sugar control throughout the day.
Uses of DAPAVILDA MET 10/100/500This medication is primarily prescribed for:
1. Type 2 Diabetes Management
Helps maintain stable blood glucose levels in adults.
2. Improving Glycemic Control
Ideal for patients who need combination therapy for better sugar control.
3. Reducing Risk of Complications
Maintaining blood sugar reduces risks of:
- Heart disease
- Kidney damage
- Nerve problems
- Vision issues
- Triple-action formula for better results
- Long-lasting effect due to sustained-release components
- Helps reduce HbA1c levels effectively
- Supports weight management (due to dapagliflozin)
- Low risk of hypoglycemia when used correctly
- Convenient single-tablet regimen
Recommended Dosage:
- Usually once daily, or as prescribed by your doctor
How to Take:
- Take with meals to reduce stomach upset
- Swallow whole—do not crush or chew (due to SR formulation)
- Take at the same time every day
Always follow your doctor’s instructions for best results.
Who Should Take DAPAVILDA MET 10/100/500?This medicine is suitable for:
- Adults diagnosed with type 2 diabetes
- Patients not controlled on metformin alone
- Individuals requiring multi-drug therapy
Like all medications, DAPAVILDA MET 10/100/500 may cause side effects.
Common Side Effects:
- Nausea
- Diarrhea
- Urinary tract infections
- Headache
Less Common but Serious:
- Lactic acidosis (rare, related to metformin)
- Dehydration
- Pancreatitis
- Kidney issues
Seek medical attention if severe symptoms occur.
Final ThoughtsManaging diabetes requires consistency, the right medication, and a healthy lifestyle. DAPAVILDA MET 10/100/500, with its combination of Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg, provides a powerful and convenient option for achieving optimal blood sugar control.
Yes! I am InterestedRequest A Callback
Glipizide Tablet 5mg
Product Price: Rs 10 / StripGet Best Price
Product Brochure
Product Details:
| Strength | 5 mg |
| Dose/Strength | 5 mg |
| Release Type | Immediate Release |
| Pack Size | 10 tablets |
| Packaging Size | 10*10 Tablets |
| Packaging Type | Stripe |
| Brand | GLIPIDIAB 5 |
| Composition | Glipizide |
| Usage | Type 2 Diabetes |
| Manufacturer | Steris Healthcare Pvt. Ltd. |
| Usage/Application | Personal |
| Shelf Life | 24 MONTHS |
Diabetes, a chronic metabolic disorder, occurs when the body either resists insulin or fails to produce enough of it. GLIPIDIAB 5 helps restore this balance by enhancing the body’s natural insulin production and improving its utilization. Its reliability, consistent bioavailability, and patient-friendly profile make it one of the most trusted medications for long-term diabetes management.
Composition
-
Active Ingredient: Glipizide IP 5 mg
-
Dosage Form: Film-coated Tablet
Pharmacological Classification
Glipizide belongs to the second-generation sulfonylureas, which are more potent and safer than earlier generations. It works by acting directly on pancreatic beta cells to enhance insulin secretion. Unlike insulin injections, which provide external insulin, Glipizide stimulates the pancreas to produce more insulin naturally—making it an effective and convenient oral therapy for diabetes control.
Mechanism of ActionGLIPIDIAB 5 functions through a dual mechanism:
-
Pancreatic Action:
-
Glipizide binds to ATP-sensitive potassium channels (KATP) on the beta-cell membrane of the pancreas.
-
This causes depolarization of the membrane, leading to the opening of calcium channels and an influx of calcium ions.
-
Increased intracellular calcium stimulates insulin granule exocytosis, resulting in increased insulin secretion.
-
-
Extra-Pancreatic Action:
-
It enhances the sensitivity of peripheral tissues (muscle and fat) to insulin, promoting glucose uptake.
-
It may also slightly reduce hepatic glucose output, further aiding in blood glucose control.
-
This coordinated mechanism ensures balanced glucose utilization and prevents hyperglycemia effectively.
Uses of GLIPIDIAB 5GLIPIDIAB 5 is primarily indicated for the management of Type 2 Diabetes Mellitus (non-insulin-dependent diabetes). It helps in:
-
Glycemic Control: Maintaining normal blood glucose levels in adult diabetics.
-
Prevention of Complications: Reduces the risk of diabetes-related complications such as neuropathy, nephropathy, and retinopathy.
-
Combination Therapy: Used alone (monotherapy) or in combination with Metformin, Pioglitazone, or other oral hypoglycemics when single-drug therapy fails to achieve target control.
-
Effective Blood Sugar Control: Rapid onset and sustained glucose-lowering effect.
-
Enhanced Insulin Secretion: Improves pancreatic response to glucose.
-
Convenient Oral Administration: Ideal for patients who prefer tablets over insulin injections.
-
Improves Quality of Life: Reduces symptoms like frequent urination, fatigue, and excessive thirst.
-
Flexible Therapy Option: Can be combined with other antidiabetic agents for better results.
-
Well-Tolerated: Minimal side effects when used as prescribed.
-
Affordable Long-Term Management: Cost-effective solution for chronic diabetes care.
Yes! I am InterestedRequest A Callback